MLNM Insider Trading Activity and SEC Form 4 Filings
MLNM insider trading summary
No open-market insider purchases or sales of Millennium Pharmaceuticals Inc (MLNM) have been reported on SEC Form 4 in the past 12 months.
Latest MLNM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 1, 2008 | Nancy A Simonian | Chief Medical Officer | Sell | $53K (2,133 @ $24.88) |
| May 1, 2008 | Anna Protopapas | Senior Vice President | Sell | $51K (2,041 @ $24.88) |
| Mar 11, 2008 | Marsha Fanucci | SVP, Chief Financial Officer | Sell | $57K (4,429 @ $12.82) |
| Mar 11, 2008 | Laurie B. Keating | SVP and General Counsel | Sell | $87K (6,784 @ $12.82) |
| Mar 7, 2008 | Marsha Fanucci | SVP, Chief Financial Officer | Sell | $80K (5,989 @ $13.34) |
| Mar 7, 2008 | Deborah Dunsire | President and CEO | Sell | $188K (14,096 @ $13.34) |
| Mar 7, 2008 | Anna Protopapas | Senior Vice President | Sell | $27K (2,010 @ $13.34) |
| Mar 7, 2008 | Laurie B. Keating | SVP and General Counsel | Sell | $43K (3,216 @ $13.34) |
| Mar 6, 2008 | Nancy A Simonian | Chief Medical Officer | Sell | $155K (11,729 @ $13.25) |
| Mar 5, 2008 | Joseph B Bolen | Chief Scientific Officer | Sell | $76K (5,606 @ $13.55) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.